Growth Metrics

Volitionrx (VNRX) Capital Leases (2018 - 2025)

Volitionrx posted quarterly Capital Leases of $317859.0 for Q4 2025, down 3.19% year-on-year from $328338.0 in Q4 2024, and down 4.13% on a QoQ basis from $331550.0 in Q3 2025.

Volitionrx (VNRX) has 8 years of Capital Leases data on file, last reported at $317859.0 in Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases fell 3.19% year-over-year to $317859.0; the trailing twelve-month figure through Dec 2025 stood at $317859.0 (down 3.19% YoY), and the FY2025 full-year result was $317859.0, down 3.19% from the prior year.
  • Capital Leases for Q4 2025 stood at $317859.0, down from $331550.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $557338.0 in Q2 2021 and bottomed at $317859.0 in Q4 2025.
  • The 5-year median for Capital Leases is $400022.0 (2023), against an average of $409979.9.
  • The widest annual swing landed in 2022, when Capital Leases decreased 23.29%; it then dropped 3.17% in 2023.
  • A 5-year view of Capital Leases shows it stood at $511086.0 in 2021, then decreased by 14.67% to $436132.0 in 2022, then dropped by 8.28% to $400022.0 in 2023, then fell by 17.92% to $328338.0 in 2024, then retreated by 3.19% to $317859.0 in 2025.
  • The last three Capital Leases figures came in at $317859.0 (Q4 2025), $331550.0 (Q3 2025), and $346291.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 317,859.00
Sep 30, 2025 331,550.00
Jun 30, 2025 346,291.00
Mar 31, 2025 330,847.00
Dec 31, 2024 328,338.00
Sep 30, 2024 366,175.00
Jun 30, 2024 363,927.00
Mar 31, 2024 379,667.00
Dec 31, 2023 400,022.00
Sep 30, 2023 395,390.00
Jun 30, 2023 419,804.00
Mar 31, 2023 429,977.00
Dec 31, 2022 436,132.00
Sep 30, 2022 408,344.00
Jun 30, 2022 447,880.00
Mar 31, 2022 486,690.00
Dec 31, 2021 511,086.00
Sep 30, 2021 532,301.00
Jun 30, 2021 557,338.00
Dec 31, 2020 601,967.00
Mar 31, 2020 583,333.00
Dec 31, 2019 607,708.00
Jun 30, 2019 642,711.00
Dec 31, 2018 720,013.00